{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:53:57Z","timestamp":1775174037355,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clbc.2023.12.007","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T17:15:48Z","timestamp":1703265348000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent Advances in the Upfront Surgical Management of the Axilla in Patients with Breast Cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Austin D.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1016\/j.clbc.2023.12.007_bib0001","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1245\/ASO.2004.11.909","article-title":"NSABP-32: phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial","volume":"11","author":"Krag","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.007_bib0002","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.007_bib0003","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.007_bib0004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2023.12.007_bib0005","doi-asserted-by":"crossref","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival amongwomen with invasive breast cancer and sentinel nodemetastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. 2017;318(10):918-926. Available at: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2653737 Accessed November 14, 2019","DOI":"10.1001\/jama.2017.11470"},{"issue":"32","key":"10.1016\/j.clbc.2023.12.007_bib0006","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.007_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"IBCSG 23-01 randomised controlled trial comparing axillary dissection versus no axillary dissection in patients with sentinel node micrometastases","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.007_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.007_bib0009","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.007_bib0010","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"issue":"49","key":"10.1016\/j.clbc.2023.12.007_bib0011","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1556\/OH.2013.29765","article-title":"[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. early results of the OTOASOR trial]","volume":"154","author":"S\u00e1volt","year":"2013","journal-title":"Orv Hetil"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.007_bib0012","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla : surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase iii, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2023.12.007_bib0013","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1\u20132 breast cancer patients presenting one or two metastatic sentinel lymph nodes: The SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2023.12.007_bib0014","series-title":"2023 San Antonio Breast Cancer Symposium","article-title":"Abstract G S02-06: recurrence-free survival following sentinel node-positive breast cancer without completion axillary lymph node dissection\u202f: first results from the international randomized SENOMAC trial","author":"de Boniface","year":"2023"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"Goyal","year":"2021","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.clbc.2023.12.007_bib0016","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1245\/s10434-014-3813-4","article-title":"Predicting the extent of nodal disease in early-stage breast cancer","volume":"21","author":"Caudle","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.007_bib0017","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2015.11.013","article-title":"Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?","volume":"222","author":"Pilewskie","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.007_bib0018","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/s10434-015-4944-y","article-title":"Does a positive axillary lymph node needle biopsy result predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.007_bib0019","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1245\/s10434-017-5935-y","article-title":"Positive ultrasound-guided lymph node needle biopsy in breast cancer may not mandate axillary lymph node dissection","volume":"24","author":"Harris","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.007_bib0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12957-019-1753-y","article-title":"Shortcomings of ultrasound-guided fine needle aspiration in the axillary management of women with breast cancer","volume":"17","author":"Attieh","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.007_bib0021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-020-05636-z","article-title":"Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis","volume":"181","author":"Yoo","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.clbc.2023.12.007_bib0022","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1245\/s10434-021-09943-7","article-title":"Palpable Adenopathy does not indicate high-volume axillary nodal disease in hormone receptor-positive breast cancer","volume":"28","author":"Crown","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2023.12.007_bib0023","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1245\/s10434-020-09228-5","article-title":"Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes: hope for more limited axillary surgery","volume":"28","author":"Angarita","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2023.12.007_bib0024","unstructured":"NCCN guidelines version 4.2023 breast cancer. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf.Accessed June 4, 2023"},{"issue":"8","key":"10.1016\/j.clbc.2023.12.007_bib0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.007_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000167759.15670.14","article-title":"A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up","volume":"242","author":"Martelli","year":"2005","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.007_bib0027","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","article-title":"Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Study Group trial 10-93","volume":"24","author":"Rudenstam","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.12.007_bib0028","doi-asserted-by":"crossref","unstructured":"Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus Tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. 2004;351(10):971-977. doi:10.1056\/NEJMOA040587","DOI":"10.1056\/NEJMoa040587"},{"issue":"19","key":"10.1016\/j.clbc.2023.12.007_bib0029","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.12.007_bib0030","unstructured":"Choosing wisely: an initiative of the ABIM foundation. 2023. Available at: https:\/\/www.choosingwisely.org\/ Accessed November 29, 2023."},{"issue":"12","key":"10.1016\/j.clbc.2023.12.007_bib0031","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.34207","article-title":"Cost-effectiveness of choosing wisely guidelines for axillary observation in women older than age 70 years with hormone receptor\u2013positive, clinically node-negative, operable breast tumors","volume":"128","author":"Hrebinko","year":"2022","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2023.12.007_bib0032","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1245\/s10434-020-08388-8","article-title":"Trends in surgical axillary management in early stage breast cancer in elderly women: continued over-treatment","volume":"27","author":"Louie","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2023.12.007_bib0033","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1245\/s10434-022-11677-z","article-title":"Variation in deescalated axillary surgical practices in older women with early-stage breast cancer","volume":"29","author":"Minami","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2023.12.007_bib0034","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1245\/s10434-020-08285-0","article-title":"Barriers and facilitators to de-implementation of the choosing wisely\u00ae guidelines for low-value breast cancer surgery","volume":"27","author":"Smith","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.007_bib0035","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1245\/s10434-017-5932-1","article-title":"Predicting Nodal positivity in women 70 years of age and older with hormone receptor-positive breast cancer to aid incorporation of a society of surgical oncology choosing wisely guideline into clinical practice","volume":"24","author":"Welsh","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.007_bib0036","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1245\/s10434-021-11007-9","article-title":"Omitting SLNB in breast cancer: is a nomogram the answer?","volume":"29","author":"Moorman","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2023.12.007_bib0037","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: The SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"issue":"25","key":"10.1016\/j.clbc.2023.12.007_bib0038","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.007_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(22)00694-5","article-title":"Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial","volume":"24","author":"Johnston","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.007_bib0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1245\/s10434-022-12203-x","article-title":"Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden","volume":"30","author":"Lee","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.007_bib0041","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1245\/s10434-022-12056-4","article-title":"Prevalence of pathologic N2\/N3 disease in postmenopausal women with clinical N0 ER+\/HER2- breast cancer","volume":"29","author":"Amlicke","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2023.12.007_bib0042","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMoa2302344","article-title":"Omitting radiotherapy after breast-conserving surgery in luminal a breast cancer","volume":"389","author":"Whelan","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2023.12.007_bib0043","unstructured":"De-escalation of breast radiation trial for hormone sensitive, HER-2 negative, oncotype recurrence score less than or equal to 18 breast cancer (DEBRA). Available at: https:\/\/clinicaltrials.gov\/study\/NCT04852887. Accessed December 14, 2023"},{"key":"10.1016\/j.clbc.2023.12.007_bib0044","article-title":"Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?","volume":"29","author":"Williams","year":"2023","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.007_bib0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamasurg.2023.2840","article-title":"Association of axillary dissection with systemic therapy in patients with clinically node-positive breast cancer","volume":"158","author":"Weber","year":"2023","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.007_bib0046","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923003117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923003117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:35:50Z","timestamp":1742229350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923003117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1526820923003117"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.12.007","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in the Upfront Surgical Management of the Axilla in Patients with Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}